OBJECTIVE: Resolution of low-grade inflammation of white adipose tissue (WAT) is one of the keys for amelioration of obesity-associated metabolic dysfunctions. We focused on the identification of adipokines, which could be involved at the early stages of resolution of WAT inflammation. METHODS AND PROCEDURE: Male C57BL/6J mice with obesity induced in response to a 22-week feeding corn oil-based high-fat (cHF) diet were divided into four groups and were fed with, for 2 weeks, control cHF diet or cHF-based diets supplemented with: (i) concentrate of n-3 long-chain polyunsaturated fatty acids, mainly eicosapentaenoic and docosahexaenoic acids (cHF+F); (ii) thiazolidinedione drug rosiglitazone (cHF+TZD); and (iii) both compounds (cHF+F+TZD). RESULTS: The short-term combined intervention exerted additive effect in the amelioration of WAT inflammation in obese mice, namely in the epididymal fat, even in the absence of any changes in either adipocyte volume or fat mass. The combined intervention elicited hypolipidaemic effect and induced adiponectin, whereas the responses to single interventions (cHF+F, cHF+TZD) were less pronounced. In addition, analysis in WAT lysates using protein arrays revealed that the levels of a small set of adipose tissue-related proteins, namely macrophage inflammatory protein 1γ, endoglin, vascular cell adhesion molecule 1 and interleukin 1 receptor antagonist, changed in response to the anti-inflammatory interventions and were strongly reduced in the cHF+F+TZD mice. These results were verified using both the analysis of gene expression and enzyme-linked immunosorbent analysis in WAT lysates. In contrast with adiponectin, which showed changing plasma levels in response to dietary interventions, the levels of the above proteins were affected only in WAT. CONCLUSIONS: We identified several adipose tissue-related proteins, which are locally involved in resolution of low-grade inflammation and remodelling of WAT.

Department of Adipose Tissue Biology Institute of Physiology of the Academy of Sciences of the Czech Republic v v i Prague Czech Republic

Paul Langerhans Group for Integrative Physiology German Diabetes Center Düsseldorf Germany

Zobrazit více v PubMed

Int J Obes (Lond). 2012 Feb;36(2):262-72 PubMed

FEBS Lett. 2003 Jul 31;548(1-3):125-30 PubMed

Lipids. 2004 Dec;39(12):1177-85 PubMed

Diabetes. 1999 Jan;48(1):134-40 PubMed

Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22504-9 PubMed

Gene. 2004 Sep 29;340(1):141-50 PubMed

J Clin Endocrinol Metab. 2002 Mar;87(3):1184-8 PubMed

Diabetologia. 2005 Nov;48(11):2365-75 PubMed

Science. 1987 Aug 21;237(4817):885-8 PubMed

PLoS One. 2012;7(6):e38834 PubMed

Diabetologia. 2011 Oct;54(10):2626-38 PubMed

Diabetes. 2010 Oct;59(10):2495-504 PubMed

Diabetes. 2006 Apr;55(4):924-8 PubMed

PLoS One. 2012;7(8):e43764 PubMed

Nat Med. 2001 Dec;7(12):1291-7 PubMed

Diabetes. 2007 Apr;56(4):1034-41 PubMed

J Clin Endocrinol Metab. 2009 Sep;94(9):3171-82 PubMed

Diabetologia. 2004 Dec;47(12):2215-25 PubMed

Int J Obes (Lond). 2007 Jun;31(6):1004-13 PubMed

Am J Physiol. 1993 Jun;264(6 Pt 2):R1111-8 PubMed

J Lipid Res. 1997 Oct;38(10):1963-72 PubMed

Clin Sci (Lond). 2009 Jan;116(1):1-16 PubMed

Diabetes. 2005 Jul;54(7):2003-11 PubMed

Diabetologia. 2007 Mar;50(3):654-65 PubMed

Nat Rev Endocrinol. 2012 Dec;8(12):709-16 PubMed

Diabetes. 2003 May;52(5):1104-10 PubMed

Ann Med. 2009;41(6):471-8 PubMed

Mol Cell Endocrinol. 2010 Jan 15;314(1):1-16 PubMed

Diabetologia. 2009 May;52(5):941-51 PubMed

PLoS One. 2011;6(11):e27126 PubMed

Am J Clin Nutr. 2012 Nov;96(5):1137-49 PubMed

Physiol Res. 2010;59(1):79-88 PubMed

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10626-31 PubMed

FEBS Lett. 1999 Feb 12;444(2-3):206-10 PubMed

Diabetes. 2005 Dec;54(12):3358-70 PubMed

PPAR Res. 2007;2007:81219 PubMed

Nat Chem Biol. 2010 Jun;6(6):433-41 PubMed

J Hum Nutr Diet. 2004 Oct;17(5):449-59 PubMed

Trends Immunol. 2011 Jul;32(7):307-14 PubMed

Diabetologia. 2006 Feb;49(2):394-7 PubMed

Int J Obes (Lond). 2008 May;32(5):772-9 PubMed

Biochem Biophys Res Commun. 2004 Oct 15;323(2):630-5 PubMed

Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E437-45 PubMed

Diabetes. 2003 Jul;52(7):1655-63 PubMed

Endocrinology. 2012 Apr;153(4):1706-16 PubMed

Diabetes. 2009 Nov;58(11):2574-82 PubMed

Nat Rev Immunol. 2006 Oct;6(10):772-83 PubMed

J Clin Invest. 2011 Jun;121(6):2111-7 PubMed

Front Immunol. 2012 Oct 22;3:298 PubMed

Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome

Reduced Number of Adipose Lineage and Endothelial Cells in Epididymal fat in Response to Omega-3 PUFA in Mice Fed High-Fat Diet